BREAST CANCER incidence in India is projected to increase by approximately 5.6% each year, corresponding to an estimated rise of nearly 0.05 million new cases annually. Globally, in 2022, about 2.3 million women were newly diagnosed with breast cancer, with the disease accounting for roughly 670,000 deaths worldwide (Cancer Epidemiology, Elsevier).
Breast cancer is a malignant disease characterized by the uncontrolled growth of abnormal cells within breast tissue, most commonly arising from the epithelial lining of the milk ducts (ductal carcinoma) or lobules (lobular carcinoma). Over time, these abnormal cells can invade surrounding tissues and metastasize to distant organs such as lymph nodes, bones, lungs, liver, and brain.
In the New England Journal of Medicine, DeSantis and coauthors have emphasized that breast cancer is not a single disease but a biologically heterogeneous group of conditions with distinct molecular subtypes, clinical behaviour, and treatment responses. These subtypes, such as hormone receptor-positive, HER2-positive, and triple-negative breast cancer, play a critical role in prognosis and therapeutic decision-making. Globally, breast cancer represents the most frequently diagnosed cancer among women and remains a leading cause of cancer-related mortality.
Factors Associated With Breast Cancer
Breast cancer development is influenced by a complex interplay of genetic, hormonal, environmental, and lifestyle-related factors. Understanding these associations is essential for risk stratification and prevention.
Genetic and Hereditary Factors
Mavaddat and coauthors reported in the journal Nature that inherited mutations in genes such as BRCA1, BRCA2, TP53, and PALB2 significantly increase the lifetime risk of breast cancer. While hereditary breast cancer accounts for approximately 5-10% of cases, individuals with these mutations often develop cancer at a younger age and may experience more aggressive disease.
Hormonal and Reproductive Factors
The Lancet, Collaborative Group on Hormonal Factors in Breast Cancer, has shown that prolonged exposure to estrogen increases breast cancer risk. Early menarche, late menopause, nulliparity, late age at first childbirth, and long-term use of hormone replacement therapy are all associated with elevated risk due to cumulative hormonal exposure.
Lifestyle and Environmental Factors
The Journal of the American Medical Association reported that modifiable lifestyle factors contribute to breast cancer risk. Excess body weight, physical inactivity, alcohol consumption, and poor dietary patterns contribute to chronic inflammation, insulin resistance, and hormonal imbalance, all of which promote carcinogenesis.
Radiation Exposure
Oxford Academic Journals, by Preston and coauthors, have demonstrated that exposure to ionizing radiation, particularly during adolescence or early adulthood, increases the risk of breast cancer later in life.
Who Is at High Risk for Breast Cancer?
Identifying high-risk populations allows for targeted screening and preventive strategies.
Women with a strong family history of breast or ovarian cancer, especially in first-degree relatives, carry a substantially increased risk. Genetic mutation carriers, particularly BRCA mutation carriers, may face lifetime risks exceeding 60%.
Age is a major determinant, with risk increasing steadily after the age of 40. However, younger women are not immune, and breast cancer in younger age groups often presents more aggressively.
Cancer epidemiology has shown that women with dense breast tissue are at higher risk and may have cancers that are more difficult to detect on routine mammography.
Lifestyle-related high-risk groups include individuals with obesity, sedentary habits, excessive alcohol intake, and chronic metabolic disorders such as type 2 diabetes.
What Are the Primary Symptoms of Breast Cancer?
Early-stage breast cancer may be asymptomatic, underscoring the importance of regular screening. When symptoms do occur, they often present subtly.
The British Medical Journal describes the most common presenting symptom as a painless lump in the breast or underarm. However, not all lumps are malignant, making clinical evaluation essential.
Other warning signs include changes in breast size or shape, skin dimpling or thickening (peau d’orange appearance), nipple retraction, unexplained nipple discharge (particularly bloody), redness or scaling of the nipple or breast skin, and persistent localized pain.
Advanced disease may present with systemic symptoms such as bone pain, unexplained weight loss, fatigue, or shortness of breath, indicating possible metastasis.
How to Prevent Breast Cancer: Evidence-Based Strategies
While not all cases of breast cancer are preventable, a substantial proportion can be reduced through lifestyle modification, early detection, and risk management.
1. Lifestyle and Dietary Interventions
The Journal of the National Cancer Institute, by Key and coauthors, has shown that maintaining a healthy body weight and engaging in regular physical activity reduces breast cancer risk by improving insulin sensitivity and lowering estrogen levels.
Dietary patterns rich in fruits, vegetables, whole grains, and healthy fats support antioxidant defense and reduce inflammation. Limiting processed foods and saturated fats is strongly advised.
2. Alcohol Moderation
The Lancet Oncology, by Scoccianti and coauthors, reports that alcohol consumption is a dose-dependent risk factor for breast cancer. Even moderate intake increases risk, emphasizing the importance of limitation or avoidance.
3. Physical Activity
Regular exercise has been shown to reduce breast cancer risk by 10-20%. MDPI Nutrients, by Friedenreich and coauthors, highlights physical activity as one of the most effective non-pharmacological preventive strategies.
4. Hormonal Management
Limiting unnecessary hormone replacement therapy and using the lowest effective dose for the shortest duration reduces hormonally driven risk.
5. Screening and Early Detection
The New England Journal of Medicine clearly mentioned that mammography remains the gold standard for early detection, significantly reducing mortality. High-risk women may benefit from earlier and more frequent screening, including MRI.
6. Preventive Pharmacology and Surgery (High-Risk Individuals)
The Journal of the American Medical Association Oncology, by Cuzick Mammography, supported by describes the role of selective estrogen receptor modulators and aromatase inhibitors in reducing breast cancer risk among high-risk women. In select cases, prophylactic mastectomy or oophorectomy may be considered under specialist guidance.
Bottom Line
Breast cancer remains a major global health challenge, but it is increasingly understood, detectable, and treatable. Advances in molecular biology, screening technologies, and personalized therapies have transformed outcomes, particularly when disease is identified early.
Evidence from leading journals revealed that risk is shaped by both non-modifiable factors and lifestyle choices. While genetics and age cannot be changed, maintaining a healthy weight, staying physically active, limiting alcohol, and participating in regular screening can significantly reduce risk and improve survival.
From a healthcare perspective, the most powerful tools against breast cancer are awareness, prevention, and early detection. Informed individuals, supported by evidence-based healthcare systems, are best positioned to reduce the burden of this disease and improve long-term outcomes.
- Written By: Dr Abdul Qayyom (MBBS, MD Scholar)
- Medically Reviewed By: Dr Avinash Singh (PhD. Pharm. Medicine)